In 2024, Medison Pharma Lithuania UAB had revenue of 2.2 million EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 2,2m € | 0 € | 0 € |
Profit | - -100.0% | 62k € +19.3% | 52k € +165.0% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - -100.0% | 74,1k € +235.0% |
Employees | - | - | - |
Overall rating | B68/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| Board (1 members: 1M/0F) |
| Description | Registered |
|---|---|
| CEO (Male) |
Medison Pharma Lithuania UAB is located at Kaunas, Užnerio g. 1-2, LT-47484, LT-LT-47484.
The shareholders of Medison Pharma Lithuania UAB include 1 Lithuanian legal entities. View ownership details →
Yes, Medison Pharma Lithuania UAB is registered as an active VAT payer with VAT number LT100015209516.
Medison Pharma Lithuania UAB was founded on February 12, 2021. The company has been operating for 5 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 5 years | 34 - 38 | 30% | |
Net revenue | 2 249 347,00 € | 4 - 8 | 90% | |
Registered capital | 2500,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Lithuanian register of legal entities.